{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-012917","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.515324+00:00","generated_at":"2026-05-20T04:58:29.977934+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Mangoceuticals raises $116K in unit offering, converts $500K note into convertible debt","bullets":["Issued 70,454 units at $1.65 each for $116,249, each unit includes 1 share and half warrant to buy 1 share at $3.00.","Amended $500K promissory note with Indigo Capital LP into convertible note at $1.50/share, removing mandatory prepayment clause.","Granted Indigo Capital warrants to purchase 275,482 shares at $1.815/share, expiring May 27, 2028.","Issued 120,000 restricted shares to Levo Healthcare for digital marketing services, vesting 10,000 shares/month over 36 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-012917","json":"https://secwatch.observer/filing/0001641172-25-012917.json","markdown":"https://secwatch.observer/filing/0001641172-25-012917.md","text":"https://secwatch.observer/filing/0001641172-25-012917.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000164117225012917/0001641172-25-012917-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000164117225012917/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:58:29.977934+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}